J&J Q4 sales up 1.7 pct, plans to divest diabetes care division
Jan 24 (Reuters) - Johnson & Johnson reported a 1.7 percent rise in fourth-quarter sales, due to a strong demand for its newer products. [Source]
Publication Date:Origin: reuters.com
Category: hotStocksNews
Topics: Johnson, sales, products, newer, for its, demand, strong, fourth-quarter, 7 percent, reported, (Reuters), division, diabetes, divest, plans
